Profile data is unavailable for this security.
About the company
CVS Health Corporation is a health solutions company. The Company's segments include Health Care Benefits, Health Services, Pharmacy & Consumer Wellness and Corporate/Other. The Health Care Benefits segment offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, PDPs and Medicaid health care management services. The Health Services segment provides a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home, and offers provider enablement solutions. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations, provides ancillary pharmacy services including pharmacy patient care programs, diagnostic testing and vaccination administration, and sells an assortment of health and wellness products and general merchandise.
- Revenue in USD (TTM)378.96bn
- Net income in USD5.28bn
- Incorporated1996
- Employees300.00k
- LocationCVS Health Corp1 Cvs DrWOONSOCKET 02895-6146United StatesUSA
- Phone+1 (401) 765-1500
- Fax+1 (302) 655-5049
- Websitehttps://cvshealth.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Quest Diagnostics Inc | 10.16bn | 892.00m | 19.14bn | 45.00k | 21.81 | 2.77 | 13.33 | 1.88 | 7.86 | 7.86 | 89.50 | 61.87 | 0.6829 | 36.71 | 7.45 | 225,733.30 | 6.18 | 8.96 | 7.13 | 10.40 | 33.15 | 36.15 | 9.05 | 12.55 | 1.31 | 6.81 | 0.4541 | 25.68 | 6.70 | 5.02 | 1.88 | 0.7317 | 1.22 | 6.90 |
| Labcorp Holdings Inc | 13.18bn | 730.80m | 21.23bn | 70.00k | 29.25 | 2.56 | 13.46 | 1.61 | 8.67 | 8.67 | 156.36 | 99.13 | 0.7721 | 19.73 | 5.88 | 188,248.60 | 4.29 | 6.16 | 5.21 | 7.33 | 27.89 | 32.18 | 5.55 | 9.17 | 1.60 | 5.48 | 0.404 | -- | 6.97 | 2.40 | 96.73 | -1.96 | 4.13 | -- |
| Natera Inc | 1.83bn | -189.76m | 22.31bn | 4.42k | -- | 17.91 | -- | 12.18 | -1.47 | -1.47 | 14.28 | 9.12 | 1.14 | 14.98 | 6.03 | 413,878.80 | -11.86 | -30.60 | -15.01 | -38.82 | 61.79 | 51.43 | -10.36 | -40.61 | 3.74 | -- | 0.0609 | -- | 56.75 | 41.20 | 56.20 | -- | 72.97 | -- |
| Humana Inc | 120.26bn | 1.71bn | 28.02bn | 65.68k | 16.42 | 1.58 | 10.11 | 0.233 | 14.14 | 14.14 | 996.52 | 147.08 | 2.38 | -- | -- | 1,831,029.00 | 3.62 | 6.19 | -- | -- | -- | -- | 1.52 | 2.69 | -- | 5.47 | 0.4275 | 15.11 | 10.70 | 12.66 | -51.51 | -14.92 | -4.82 | 10.49 |
| Elevance Health Inc | 183.12bn | 5.92bn | 78.14bn | 103.16k | 13.49 | 1.84 | 10.50 | 0.4267 | 25.63 | 25.63 | 792.32 | 188.37 | 1.58 | -- | -- | 1,775,180.00 | 5.10 | 5.80 | -- | -- | -- | -- | 3.23 | 3.73 | -- | 7.19 | 0.4131 | 21.78 | 3.19 | 11.14 | -0.1169 | 4.46 | 3.12 | 15.30 |
| Cigna Group | 255.37bn | 5.03bn | 82.49bn | 73.50k | 17.11 | 2.07 | 10.17 | 0.323 | 18.05 | 18.05 | 915.18 | 149.04 | 1.68 | 46.74 | 10.75 | 3,474,395.00 | 3.55 | 3.91 | 5.52 | 5.49 | 10.25 | 12.70 | 2.11 | 3.12 | 0.6885 | 4.37 | 0.4297 | 19.80 | 26.56 | 9.98 | -33.50 | -7.62 | 6.01 | 168.67 |
| CVS Health Corp | 378.96bn | 5.28bn | 83.01bn | 300.00k | 15.68 | 1.08 | 8.42 | 0.219 | 4.19 | 4.19 | 300.52 | 60.96 | 1.50 | 19.31 | 36.03 | 1,263,200.00 | 2.08 | 2.75 | 3.15 | 3.91 | 14.05 | 16.20 | 1.38 | 2.01 | 0.6273 | 3.86 | 0.4563 | 45.34 | 4.20 | 7.74 | -44.70 | -7.00 | 2.51 | 5.87 |
| HCA Healthcare Inc | 71.59bn | 5.78bn | 91.01bn | 226.00k | 16.81 | -- | 9.05 | 1.27 | 22.51 | 22.51 | 278.35 | -14.48 | 1.23 | 5.87 | 6.78 | 316,747.80 | 11.44 | 12.23 | 15.90 | 16.34 | 84.85 | 84.36 | 9.33 | 10.35 | 1.06 | 5.28 | 1.01 | 10.16 | 8.67 | 6.58 | 9.88 | 10.45 | 3.23 | 10.53 |
| UnitedHealth Group Inc | 410.06bn | 22.11bn | 271.70bn | 400.00k | 12.54 | 2.87 | 10.03 | 0.6626 | 23.89 | 23.89 | 443.07 | 104.44 | 1.38 | -- | -- | 1,025,143.00 | 7.72 | 7.94 | -- | -- | -- | -- | 5.59 | 5.64 | -- | 8.25 | 0.4359 | 33.65 | 7.71 | 10.57 | -35.64 | 0.8049 | 11.06 | 14.59 |
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Mar 2025 | 112.17m | 8.90% |
| Dodge & Coxas of 31 Mar 2025 | 73.46m | 5.83% |
| Capital Research & Management Co. (World Investors)as of 31 Mar 2025 | 68.40m | 5.43% |
| BlackRock Fund Advisorsas of 31 Mar 2025 | 64.96m | 5.15% |
| SSgA Funds Management, Inc.as of 31 Mar 2025 | 57.99m | 4.60% |
| Geode Capital Management LLCas of 31 Mar 2025 | 27.96m | 2.22% |
| Capital Research & Management Co. (International Investors)as of 31 Mar 2025 | 26.19m | 2.08% |
| Capital Research & Management Co. (Global Investors)as of 31 Mar 2025 | 18.73m | 1.49% |
| Norges Bank Investment Managementas of 31 Dec 2024 | 18.70m | 1.48% |
| Pzena Investment Management LLCas of 31 Mar 2025 | 17.68m | 1.40% |
